Biogen has decided to advance its tau-targeting Alzheimer's disease drug diranersen (BIIB080) into a phase 3 trial programme, despite a phase 2 trial missing its main efficacy measure. In the 18-month ...
It’s safe to say that AI has firmly captured the interest of decision-makers across the industry. But, as the space continues ...
Cardiac rhythm management is undergoing a significant shift. For decades, cardiac resynchronisation therapy has helped restore synchrony in patients with heart failure and electrical conduction ...
Regenxbio is pitching at FDA approval next year for its Duchenne muscular dystrophy (DMD) gene therapy RGX-202, after ...
Bladder cancer has been billed by AstraZeneca as a key growth area for its immunotherapy Imfinzi, an ambition that has now ...
Parallel reviews of new medicines by the UK's MHRA drug regulator and reimbursement authority NICE benefit industry more than patients and the NHS. That is the contention voiced by Huseyin Naci at the ...
Immune cell therapies have transformed the treatment of certain blood cancers over the past decade. However, when it comes to ...
NHS England has announced a deal with AbbVie, Gilead, and Merck, Sharpe and Dohme (MSD) that aims to eliminate hepatitis C from the country - although it has had to drop a 2025 target date because of ...
A California jury has awarded $40 million in damages to two women who sued Johnson & Johnson, claiming that its talc-based Baby Powder product led to their ovarian cancer. The jury in a Los Angeles ...
Bill Gates has made a $50 million donation to the Dementia Discovery Fund, a collaboration between pharma, the UK government and the charity Alzheimer’s Research UK, that aims to challenge the ...
Madrigal Pharma could be just weeks away from becoming the first drugmaker to claim EU approval for a treatment for metabolic dysfunction-associated steatohepatitis (MASH). The EMA's human medicines ...
Roche's Genentech unit has started work on a $700 million manufacturing facility in North Carolina, part of a promised $50 billion investment in the US. The plant – its first on the East Coast of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results